US Patent 10961294 Ultra-long acting insulin-Fc fusion proteins and methods of use
Patent 10961294 was granted and assigned to Akston Biosciences Corporation on March, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10961294 Ultra-long acting insulin-Fc fusion proteins and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
